Meropenem Injection, Powder, For Solution
Product Images NDC 63323-508

Product Visual Gallery

This gallery contains 6 technical images submitted to the FDA as part of the official labeling for Meropenem (NDC 63323-508). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Fresenius Kabi Usa, Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Mer0a 0001 01

FDA Label Image

Mer0a 0001 02

FDA Label Image

Mer0a 0001 03

Meropenem for Injection is a prescription medication equivalent to 500 mg/vial. It is given intravenously and each vial contains MR U2 UL. The sodium content of the medication is approximately 45.1 mg (1.96 mEq). It is only for intravenous use and comes in a sterile single-dose vial. It is manufactured under the trademark novaplus by Vizient, Inc.*

FDA Label Image

Mer0a 0001 04

This is a description of Meropenem, an injectable antibiotic drug. It is available in a 500mg dosage, contained in a sterile vial for single-use. The drug is only administered intravenously and each vial contains 500mg of meropenem activity. The sodium content in each vial is approximately 45.1mg (1.96 mEq). The National Drug Code (NDC) for this drug is 63323-507-21, and the product code is NP350720.*

FDA Label Image

Mer0a 0001 05

This is a description of Meropenem for Injection, which is a medication used for intravenous use only. The medication is available in single-dose vials, with each vial containing an equivalent of 1 gram/wal of Meropenem. The medication is used for treating severe bacterial infections. The text also includes the NDC code and a trademark referred to as "novaplus."*

FDA Label Image

Mer0a 0001 06

This is a description of a medication for intravenous use called Meropenem. The medication comes in vial form, with each vial containing the equivalent of 1 gram of Meropenem. In addition, the vials contain a sodium content of approximately 90.2 mg (3.92 mEq). The medication is produced by a company called novaplus, and is sold in packages of 10 vials.*

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.